Andrew Gillum is a focal point of a recently issued federal grand jury subpoena that demands information on the former Democratic candidate for governor, his campaign, his political committee, a wealthy donor, a charity he worked for and a former employer.
The subpoena, obtained by the Tampa Bay Times and previously unreported, could reflect a new level of federal inquiry into Gillum, the former mayor of Tallahassee who narrowly lost to Republican Ron DeSantis last year.
Throughout his campaign last year, Gillum insisted that he was not a target of a sprawling FBI investigation of Tallahassee city hall, which has taken at least three years and resulted in three arrests. Last year, he told the Tallahassee Democrat: “Twenty-plus subpoenas have been issued and not one of them has anything to do with me.”
But the recent one does. Previously, the investigation had centered on corruption inside Tallahassee government, including during Gillum’s time as mayor. The newer subpoena is more focused on Gillum’s 2018 campaign and people and organizations with clear ties to Gillum, but with less obvious connections to Tallahassee city hall.
4 days, 3 hours ago
Iwo Jima Ceremony Cancelled Due to Coronavirus
Saturday marks the battle's 75th anniversary.
4 days, 22 hours ago
Joe Biden Cancels Coronavirus Briefing After Series Of Media Mishaps
Biden's briefings aren't going as planned...
5 days, 3 hours ago
Businesses Stepping Up To Help Fight Coronavirus
Companies all across the United States are pitching in to help slow the spread of Coronavirus and lessen its impact on American workers.
5 days, 4 hours ago
White House Reaches Deal With Lawmakers on $2 Trillion Coronavirus Stimulus Bill
Lawmakers and the Trump administration reached an agreement on an estimated $2 trillion stimulus package.
6 days, 2 hours ago
Leading economists warn 'Medicare for All' would trigger shortages, stifle innovation
More than 50 leading U.S. economists and professors have signed an open letter warning that “Medicare for All” would trigger shortages, degrade quality and discourage medical innovation.